Carlos Alberto Gonzalez-Villarreal

Carlos Alberto Gonzalez-Villarreal
Verified
Carlos verified their affiliation via an institutional email.
Verified
Carlos verified their affiliation via an institutional email.
  • PhD
  • Professor (Assistant) at Universidad de Monterrey

About

10
Publications
5,898
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
96
Citations
Introduction
Currently working in possible cell-gene therapies involving Mesenchymal stem cells and, in future projects, exosomes, in order to determine its effectivity as putative and promisory cancer therapies. To avoid internalization of cells or, more importantly, exogenous DNA (since most transgenes are integrated by means of lentiviral vectors), exosomes are currently being studied.
Current institution
Universidad de Monterrey
Current position
  • Professor (Assistant)
Additional affiliations
November 2018 - present
Universidad de Monterrey
Position
  • Professor
Description
  • Professor and researcher
November 2018 - present
Universidad de Monterrey
Position
  • Professor
Description
  • Pharmacology laboratory coordinator, professor in medicine school and researcher
Education
August 2014 - October 2018
Autonomous University of Nuevo León
Field of study
  • molecular biolody

Publications

Publications (10)
Article
Full-text available
Combined gene and cell therapy are promising strategies for cancer treatment. Given the complexity of cancer, several approaches are actively studied to fight this disease. Using mesenchymal stem cells (MSCs) has demonstrated dual antitumor and protumor effects as they exert massive immune/regulatory effects on the tissue microenvironment. MSCs hav...
Article
Full-text available
A key problem in colorectal cancer (CRC) is the development of resistance to current therapies due to the presence of cancer stem cells (CSC), which leads to poor prognosis. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a protein that activates apoptosis in cancer cells through union with TRAIL death receptors. Cell therapies a...
Article
Full-text available
Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with properties, such as self-renewal, differentiation, and tumorigenicity. CSCs have been proposed as a plausible therapeutic target as they are responsible for tumor recurrence, metastasis, and conventional therapy resistance. Selectively targeting CSCs is a promising strat...
Article
Full-text available
Background: Cancer treatment has many side effects; therefore, more efficient treatments are needed. Mesenchymal stem cells (MSC) have immunoregulatory properties, tumor site migration and can be genetically modified. Some proteins, such as soluble TRAIL (sTRAIL) and interleukin-12 (IL-12), have shown antitumoral potential, thus its combination in...
Article
Full-text available
Gastrointestinal adenocarcinomas are one of the world’s deadliest cancers. Cancer stem cells and the tissue microenvironment are highly regulated by cell and molecular mechanisms. Cancer stem cells are essential for maintenance and progression and are associated with resistance to conventional treatments. This article reviews the current knowledge...
Article
Full-text available
As the understanding of cancer grows, new therapies have been proposed to improve the well-known limitations of current therapies, whose efficiency relies mostly on early detection, surgery and chemotherapy. Mesenchymal stem cells (MSCs) have been introduced as a promissory and effective therapy. This fact is due to several useful features of MSCs,...
Article
Full-text available
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes coronavirus disease-2019 (COVID-19) has provoked a global pandemic, mainly affecting the respiratory tract; however, a percentage of infected individuals can develop gastrointestinal (GI) symptoms. Some studies describe the development of GI symptoms and how they affect th...
Article
Full-text available
Colorectal carcinoma (CRC) is a leading cause of cancer mortality. Tumorigenesis is a dynamic process wherein cancer stem cells (CSCs) and their microenvironment promote initiation, progression, and metastasis. Metastatic colonization is an inefficient process that is very complex and is poorly understood; however, in most cases, metastatic disease...
Article
Full-text available
Purpose: Advanced cancer is a catastrophic medical condition that is generally treated with surgery and conventional anticancer drugs, which are very toxic and often fail. A promising alternative is using genetically engineered mesenchymal stem cells. A popular method for genetically engineering mesenchymal stem cells (MSCs) is by employing transf...
Article
Full-text available
The implantation of adult mesenchymal stem cells (MSCs) has become a promising alternative in cancer treatments. Accordingly, in this article we revised the ultimate advances in the knowledge on the MSC-homing mechanism, the cancer cell and MSCs interactions and the microvesicles and exosomes used by malignant cells to transport and deliver pro-can...

Network

Cited By